1	Engagement	engagement	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	Lewis	Lewis	_	_	_	_	_	_	_
5	X	X	_	_	_	_	_	_	_
6	antigen	antigen	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	CD15	cd15	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	results	result	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	monocyte	monocyte	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	reported	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	monocyte	monocyte	_	_	_	_	_	_	_
6	adhesion	adhesion	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	tumor	tumor	_	_	_	_	_	_	_
9	necrosis	necrosis	_	_	_	_	_	_	_
10	factor-alpha	factor-alpha	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	TNF-alpha)-treated	tnf-alpha)-treated	_	_	_	_	_	_	_
13	endothelial	endothelial	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	increased	increase	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	tissue	tissue	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	CD36	cd36	_	_	_	_	_	_	_
22	on	on	_	_	_	_	_	_	_
23	monocytes	monocyte	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	immunological	immunological	_	_	_	_	_	_	_
3	cross-linking	cross-linking	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	mimic	mimic	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	engagement	engagement	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	natural	natural	_	_	_	_	_	_	_
10	ligands	ligand	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	we	we	_	_	_	_	_	_	_
13	now	now	_	_	_	_	_	_	_
14	show	show	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	CD15	CD15	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	Lewis	Lewis	_	_	_	_	_	_	_
19	X	X	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	monocyte	monocyte	_	_	_	_	_	_	_
24	counter-receptor	counter-receptor	_	_	_	_	_	_	_
25	for	for	_	_	_	_	_	_	_
26	endothelial	endothelial	_	_	_	_	_	_	_
27	selectins	selectin	_	_	_	_	_	_	_
28	may	may	_	_	_	_	_	_	_
29	participate	participate	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	this	this	_	_	_	_	_	_	_
32	response	response	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	used	use	_	_	_	_	_	_	_
3	cytokine	cytokine	_	_	_	_	_	_	_
4	production	production	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	readout	readout	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	monocyte	monocyte	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	found	find	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	CD15	cd15	_	_	_	_	_	_	_
15	cross-linking	cross-linking	_	_	_	_	_	_	_
16	induced	induce	_	_	_	_	_	_	_
17	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
18	release	release	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	peripheral	peripheral	_	_	_	_	_	_	_
21	blood	blood	_	_	_	_	_	_	_
22	monocytes	monocyte	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	monocytic	monocytic	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	line	line	_	_	_	_	_	_	_
30	MM6	mm6	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Quantitative	quantitative	_	_	_	_	_	_	_
2	reverse	reverse	_	_	_	_	_	_	_
3	transcriptase-polymerase	transcriptase-polymerase	_	_	_	_	_	_	_
4	chain	chain	_	_	_	_	_	_	_
5	reaction	reaction	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	RT-PCR	RT-PCR	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	showed	show	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	increase	increase	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	steady-state	steady-state	_	_	_	_	_	_	_
14	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
15	mRNA	mRNA	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	3	3	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	4	4	_	_	_	_	_	_	_
20	hours	hour	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	cross-linking	cross-linking	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	CD15	CD15	_	_	_	_	_	_	_
2	cross-linking	cross-linking	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	concomitantly	concomitantly	_	_	_	_	_	_	_
5	increased	increase	_	_	_	_	_	_	_
6	interleukin-1	interleukin-1	_	_	_	_	_	_	_
7	beta	beta	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	IL-1	il-1	_	_	_	_	_	_	_
10	beta	beta	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	mRNA	mRNA	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	while	while	_	_	_	_	_	_	_
15	no	no	_	_	_	_	_	_	_
16	apparent	apparent	_	_	_	_	_	_	_
17	change	change	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	observed	observe	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	levels	level	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	beta-actin	beta-actin	_	_	_	_	_	_	_
25	mRNA	mRNA	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	indicating	indicate	_	_	_	_	_	_	_
28	specificity	specificity	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	examine	examine	_	_	_	_	_	_	_
3	transcriptional	transcriptional	_	_	_	_	_	_	_
4	regulation	regulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	cytokine	cytokine	_	_	_	_	_	_	_
7	genes	gene	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	CD15	cd15	_	_	_	_	_	_	_
10	engagement	engagement	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	CAT	CAT	_	_	_	_	_	_	_
14	plasmid	plasmid	_	_	_	_	_	_	_
15	reporter	reporter	_	_	_	_	_	_	_
16	construct	construct	_	_	_	_	_	_	_
17	containing	contain	_	_	_	_	_	_	_
18	IL-1	il-1	_	_	_	_	_	_	_
19	beta	beta	_	_	_	_	_	_	_
20	promoter/enhancer	promoter/enhancer	_	_	_	_	_	_	_
21	sequences	sequence	_	_	_	_	_	_	_
22	was	be	_	_	_	_	_	_	_
23	introduced	introduce	_	_	_	_	_	_	_
24	into	into	_	_	_	_	_	_	_
25	MM6	MM6	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Subsequent	subsequent	_	_	_	_	_	_	_
2	cross-linking	cross-linking	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	CD15	CD15	_	_	_	_	_	_	_
5	increased	increase	_	_	_	_	_	_	_
6	CAT	CAT	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	CD15	CD15	_	_	_	_	_	_	_
2	engagement	engagement	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	monoclonal	monoclonal	_	_	_	_	_	_	_
5	antibody	antibody	_	_	_	_	_	_	_
6	also	also	_	_	_	_	_	_	_
7	attenuated	attenuate	_	_	_	_	_	_	_
8	IL-1	il-1	_	_	_	_	_	_	_
9	beta	beta	_	_	_	_	_	_	_
10	transcript	transcript	_	_	_	_	_	_	_
11	degradation	degradation	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	demonstrating	demonstrate	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	signaling	signaling	_	_	_	_	_	_	_
16	via	via	_	_	_	_	_	_	_
17	CD15	CD15	_	_	_	_	_	_	_
18	also	also	_	_	_	_	_	_	_
19	had	have	_	_	_	_	_	_	_
20	posttranscriptional	posttranscriptional	_	_	_	_	_	_	_
21	effects	effect	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	extracts	extract	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	anti-CD15	anti-cd15	_	_	_	_	_	_	_
5	cross-linked	cross-linked	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	demonstrated	demonstrate	_	_	_	_	_	_	_
8	enhanced	enhance	_	_	_	_	_	_	_
9	levels	level	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	transcriptional	transcriptional	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	activator	activator	_	_	_	_	_	_	_
15	protein-1	protein-1	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	minimally	minimally	_	_	_	_	_	_	_
18	changed	change	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factor-kappa	factor-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	did	do	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	affect	affect	_	_	_	_	_	_	_
27	SV40	sv40	_	_	_	_	_	_	_
28	promoter	promoter	_	_	_	_	_	_	_
29	specific	specific	_	_	_	_	_	_	_
30	protein-1	protein-1	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	engagement	engagement	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	CD15	cd15	_	_	_	_	_	_	_
7	on	on	_	_	_	_	_	_	_
8	monocytes	monocyte	_	_	_	_	_	_	_
9	results	result	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	monocyte	monocyte	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	its	its	_	_	_	_	_	_	_
5	well-recognized	well-recognized	_	_	_	_	_	_	_
6	adhesive	adhesive	_	_	_	_	_	_	_
7	role	role	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	CD15	CD15	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	function	function	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	important	important	_	_	_	_	_	_	_
15	signaling	signal	_	_	_	_	_	_	_
16	molecule	molecule	_	_	_	_	_	_	_
17	capable	capable	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	initiating	initiate	_	_	_	_	_	_	_
20	proinflammatory	proinflammatory	_	_	_	_	_	_	_
21	events	event	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	monocytes	monocyte	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	come	come	_	_	_	_	_	_	_
26	into	into	_	_	_	_	_	_	_
27	contact	contact	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	activated	activate	_	_	_	_	_	_	_
30	endothelium	endothelium	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

